208 related articles for article (PubMed ID: 7019703)
1. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.
Santen RJ; Worgul TJ; Samojlik E; Interrante A; Boucher AE; Lipton A; Harvey HA; White DS; Smart E; Cox C; Wells SA
N Engl J Med; 1981 Sep; 305(10):545-51. PubMed ID: 7019703
[TBL] [Abstract][Full Text] [Related]
2. [Chemical adrenalectomy induced by aminoglutethimide in the treatment of breast cancer. A review].
Cikes M
Schweiz Med Wochenschr; 1983 Mar; 113(11):382-91. PubMed ID: 6342129
[TBL] [Abstract][Full Text] [Related]
3. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
Sterns EE; Bird CE; Mackie KW
Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
[TBL] [Abstract][Full Text] [Related]
4. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
Samojlik E; Veldhuis JD; Wells SA; Santen RJ
J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
[TBL] [Abstract][Full Text] [Related]
5. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
[TBL] [Abstract][Full Text] [Related]
6. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
[TBL] [Abstract][Full Text] [Related]
7. Comparison of surgical adrenalectomy to medical adrenalectomy in patients with metastatic carcinoma of the breast.
Wells SA; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H; White D; Smart E; Cox C; Santen RJ
Cancer Res; 1982 Aug; 42(8 Suppl):3454s-3457s. PubMed ID: 7044527
[No Abstract] [Full Text] [Related]
8. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
Rose C; Kamby C; Mouridsen HT; Bastholt L; Brincker H; Skovgaard-Poulsen H; Andersen AP; Loft H; Dombernowsky P; Andersen KW
Breast Cancer Res Treat; 1986; 7 Suppl():S45-50. PubMed ID: 3527306
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
[TBL] [Abstract][Full Text] [Related]
10. [Low-dose aminoglutethimide (500 mg/day) and hydrocortisone (30 mg/day) in advanced cancer of breast].
Bonneterre J; Pion JM; Demaille A
Bull Cancer; 1987; 74(3):241-7. PubMed ID: 3304478
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
12. Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.
Santen RJ
Breast Cancer Res Treat; 1981; 1(3):183-202. PubMed ID: 6293627
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogen treatment of breast cancer: an overview.
Pearson OH; Manni A; Arafah BM
Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
[TBL] [Abstract][Full Text] [Related]
14. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
16. [The use of aminoglutethimide in the treatment of metastatic breast cancer].
Bellora MG; Ciancio A; Ferrero A; Bergamino T; Zola P; Sismondi P
Minerva Ginecol; 1991 Dec; 43(12):589-93. PubMed ID: 1819778
[TBL] [Abstract][Full Text] [Related]
17. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
Höffken K; Kempf H; Miller AA; Miller B; Schmidt CG; Faber P; Kley HK
Cancer Treat Rep; 1986 Oct; 70(10):1153-7. PubMed ID: 3756937
[TBL] [Abstract][Full Text] [Related]
18. [Aminoglutethimide therapy in advanced breast cancer].
Kühböck J; Ludwig H; Pötzi P; Zielinski C
Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
[TBL] [Abstract][Full Text] [Related]
19. Medical adrenalectomy with aminoglutethimide-cortisol in the treatment of metastatic breast carcinoma.
Paridaens R; Van Haelen C; Heuson JC
Eur J Cancer (1965); 1980; Suppl 1():103-6. PubMed ID: 7318860
[No Abstract] [Full Text] [Related]
20. [Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day].
Bonneterre J; Coppens H; Mauriac L; Rouesse J; Fargeot P; Metz R; Armand JP; Mathieu A; Tubiana M; Cappelaere P
Acta Clin Belg Suppl; 1986; 11():41-8. PubMed ID: 3521171
[No Abstract] [Full Text] [Related]
[Next] [New Search]